Clearside Biomedical Files 8-K on Financials
Ticker: CLSDQ · Form: 8-K · Filed: May 14, 2025 · CIK: 1539029
| Field | Detail |
|---|---|
| Company | Clearside Biomedical, Inc. (CLSDQ) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
TL;DR
Clearside Biomedical dropped an 8-K on May 14th detailing their financial condition and results. Check it for the latest numbers.
AI Summary
On May 14, 2025, Clearside Biomedical, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Clearside Biomedical's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Clearside Biomedical, Inc. (company) — Registrant
- May 14, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 45-2437375 (identifier) — IRS Employer Identification No.
- 900 North Point Parkway Suite 200 (address) — Principal Executive Offices
- Alpharetta, Georgia (location) — Principal Executive Offices City and State
- 30005 (zip_code) — Principal Executive Offices Zip Code
- (678) 270-3631 (phone_number) — Registrant's Telephone Number
FAQ
What specific financial results are being reported by Clearside Biomedical in this 8-K?
The provided excerpt indicates the filing concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific financial figures.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 14, 2025.
What is the principal executive office address for Clearside Biomedical, Inc.?
The principal executive office address is 900 North Point Parkway Suite 200, Alpharetta, Georgia 30005.
Under which section of the Securities Exchange Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the IRS Employer Identification Number for Clearside Biomedical, Inc.?
The IRS Employer Identification Number for Clearside Biomedical, Inc. is 45-2437375.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Clearside Biomedical, Inc. (CLSDQ).